Release Date: 29/01/20 09:53 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 260.64KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%